| Michael Sze, MD | |
|
845 Helen Dr, Lebanon, PA 17042-7493 | |
| (717) 273-8835 | |
| (717) 202-0100 |
| Full Name | Michael Sze |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 845 Helen Dr, Lebanon, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710914031 | NPI | - | NPPES |
| MD-14068 | Other | HI | HI LIC. |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD00044633 (Washington) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD475060 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
An international group of researchers has identified 11 new genes that offer important new insights into the disease pathways involved in Alzheimer's disease. The highly collaborative effort involved scanning the DNA of over 74,000 volunteers-the largest genetic analysis yet conducted in Alzheimer's research-to discover new genetic risk factors linked to late-onset Alzheimer's disease, the most common form of the disorder.
Researchers from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, believe the key to making future generations healthier could lie before the mother becomes pregnant.
"Indonesia's government has quietly issued an order to override the patents on seven important medicines used to treat people with HIV and hepatitis B and allow cheap versions to be made by local drug companies," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.
› Verified 5 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326060492 PECOS PAC ID: 2961307467 Enrollment ID: O20031205000629 |
News Archive
An international group of researchers has identified 11 new genes that offer important new insights into the disease pathways involved in Alzheimer's disease. The highly collaborative effort involved scanning the DNA of over 74,000 volunteers-the largest genetic analysis yet conducted in Alzheimer's research-to discover new genetic risk factors linked to late-onset Alzheimer's disease, the most common form of the disorder.
Researchers from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, believe the key to making future generations healthier could lie before the mother becomes pregnant.
"Indonesia's government has quietly issued an order to override the patents on seven important medicines used to treat people with HIV and hepatitis B and allow cheap versions to be made by local drug companies," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.
› Verified 5 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
An international group of researchers has identified 11 new genes that offer important new insights into the disease pathways involved in Alzheimer's disease. The highly collaborative effort involved scanning the DNA of over 74,000 volunteers-the largest genetic analysis yet conducted in Alzheimer's research-to discover new genetic risk factors linked to late-onset Alzheimer's disease, the most common form of the disorder.
Researchers from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, believe the key to making future generations healthier could lie before the mother becomes pregnant.
"Indonesia's government has quietly issued an order to override the patents on seven important medicines used to treat people with HIV and hepatitis B and allow cheap versions to be made by local drug companies," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Sze, MD 845 Helen Dr, Lebanon, PA 17042-7493 Ph: (717) 273-8835 | Michael Sze, MD 845 Helen Dr, Lebanon, PA 17042-7493 Ph: (717) 273-8835 |
News Archive
An international group of researchers has identified 11 new genes that offer important new insights into the disease pathways involved in Alzheimer's disease. The highly collaborative effort involved scanning the DNA of over 74,000 volunteers-the largest genetic analysis yet conducted in Alzheimer's research-to discover new genetic risk factors linked to late-onset Alzheimer's disease, the most common form of the disorder.
Researchers from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, believe the key to making future generations healthier could lie before the mother becomes pregnant.
"Indonesia's government has quietly issued an order to override the patents on seven important medicines used to treat people with HIV and hepatitis B and allow cheap versions to be made by local drug companies," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.
› Verified 5 days ago
Dr. Daniel P Rollo, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 300 Willow St, Lebanon, PA 17046 Phone: 717-273-8835 Fax: 717-273-0728 | |
Dr. Maryanne T. Mclaughlin, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 | |
Dr. Roger A. Hine, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 | |
Dennis J Easter, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 | |
Nathan Adam Keller, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 | |
James A Nicholson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30 N 4th St Fl 2, Lebanon, PA 17046 Phone: 717-274-0474 Fax: 717-270-2374 | |
Dr. Raliat Oluwafunke Bashua, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 845 Helen Dr, Lebanon, PA 17042 Phone: 717-273-8835 Fax: 717-202-0100 |